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During infection, enterohaemorrhagic Escherichia coli (EHEC) takes over the actin cytoskeleton of eukaryotic cells by injecting the EspF U protein into the host cytoplasm 1, 2 . EspF U controls actin by activating members of the Wiskott-Aldrich syndrome protein (WASP) family [1] [2] [3] [4] [5] . Here we show that EspF U binds to the autoinhibitory GTPase binding domain (GBD) in WASP proteins and displaces it from the activity-bearing VCA domain (for verprolin homology, central hydrophobic and acidic regions). This interaction potently activates WASP and neural (N)-WASP in vitro and induces localized actin assembly in cells. In the solution structure of the GBD-EspF U complex, EspF U forms an amphipathic helix that binds the GBD, mimicking interactions of the VCA domain in autoinhibited WASP. Thus, EspF U activates WASP by competing directly for the VCA binding site on the GBD. This mechanism is distinct from that used by the eukaryotic activators Cdc42 and SH2 domains, which globally destabilize the GBD fold to release the VCA [6] [7] [8] . Such diversity of mechanism in WASP proteins is distinct from other multimodular systems, and may result from the intrinsically unstructured nature of the isolated GBD and VCA elements. The structural incompatibility of the GBD complexes with EspF U and Cdc42/SH2, plus high-affinity EspF U binding, enable EHEC to hijack the eukaryotic cytoskeletal machinery effectively.
Pathogenic bacteria often target the host actin cytoskeleton during infection to assist entry, cell-to-cell spreading and intimate attachment to host membranes [9] [10] [11] [12] [13] . EHEC (serotype O157:H7) is a foodborne human pathogen that causes severe diarrhoea and haemolytic uraemic syndrome 14 . During infection, EHEC binds eukaryotic host intestinal epithelial cells and secretes translocated intimin receptor (Tir) and EspF U (also known as TccP) into the host cell 1, 2 . The secreted Tir localizes in the host plasma membrane and, on clustering by binding to the bacterial outer surface protein intimin, recruits EspF U by means of its carboxy-terminal cytoplasmic domain 3 . EspF U in turn then hijacks members of the WASP family, which locally stimulate the actin nucleation factor, the Arp2/3 complex [1] [2] [3] [4] [5] . Together, these interactions induce the formation of an actin-rich membrane protrusion beneath the site of EHEC attachment, termed an actin pedestal 1, 2, 15 . WASP proteins activate the Arp2/3 complex through a C-terminal VCA domain 16 . In free WASP, this activity is blocked by intramolecular interactions with a central GTPase binding domain (GBD). Structural and biochemical studies have shown that the GBD sequesters an amphipathic helix in the C region of the VCA that is necessary for activation of the Arp2/3 complex, resulting in autoinhibition 7, 17, 18 . WASP can be allosterically activated by several intracellular ligands, including Cdc42 and (for phosphorylated WASP) SH2 domains 8, 19 . These ligands bind to WASP and N-WASP in a manner that is structurally incompatible with the autoinhibited fold of the GBD. Thus, they activate WASP by globally destabilizing the GBD, consequently releasing the VCA 6, 8, 20, 21 . EspF U is composed of an amino-terminal signal sequence which is necessary for translocation into the eukaryotic host, followed by 2-7 nearly identical 47-residue repeats (Fig. 1a ) 22 . Each full repeat consists of an N-terminal 27-residue hydrophobic segment and a C-terminal 20-residue proline-rich segment. Previous studies have shown that EspF U can bind to the N-WASP GBD and activate N-WASP towards the Arp2/3 complex in actin assembly assays in vitro 1, 2, 4 . A similar sequence is found in the related bacterial effector EspF, which also can activate N-WASP ( Supplementary Fig. 1 ) 23 .
To understand EspF U -mediated activation, we examined fragments containing the full 47-residue fifth repeat (R47; Fig. 1 and Supplementary Fig. 1 ) and an N-terminal 33-residue fragment lacking most of the proline-rich sequence (R33). In Arp2/3-mediated pyreneactin assembly assays, R47 and R33 appreciably and similarly enhanced the activities of autoinhibited N-WASP and WASP proteins (N-WASP C and GBD-VCA, respectively; Fig. 1b and Supplementary  Fig. 2 ). Titration of R47 into N-WASP C (C-terminal residues 193-501, containing the GBD, proline-rich segment and VCA) produced a monotonic increase in actin assembly rate ( Fig. 1c and Supplementary  Fig. 3 ), which reached a plateau value similar to that of the N-WASP VCA. Thus, the endpoint of the titration produces a state that biochemically resembles free N-WASP VCA. Fitting the data to a singlesite binding isotherm yields a K Act (the concentration of EspF U R47 required for half-maximal activation in actin assembly assays) of 24 nM, approximating the dissociation constant (K d ) of R47 for N-WASP C as 35 nM ( Supplementary Fig. 4 ). EspF U binds to N-WASP more than 100-fold more strongly than Cdc42 does (ref. 21) , resulting in much greater potency in actin assembly assays (Fig. 1c ). This higher affinity should enable EspF U to hijack N-WASP away from its endogenous regulators in vivo 21 . Cdc42 and SH2 domains activate WASP by physically displacing the VCA from the GBD 7, 8 . EspF U R33 disrupted GBD-VCA interactions similarly ( Supplementary Fig. 5 ), indicating that it also binds the GBD in a manner that is incompatible with the autoinhibitory interactions. The combined data show that EspF U R33 is functionally equivalent to Cdc42 and SH2 domains: all three ligands activate WASP and N-WASP by releasing the VCA from the GBD.
The WASP GBD is largely unstructured on its own, but folds to a well-defined conformation on binding VCA 7 . 1 H-
15
N and 1 H-13 C amide and methyl transverse relaxation-optimized spectroscopy (TROSY) NMR spectra showed that EspF U R33, or a five-repeat fragment, R47 5 , also induced folding of the GBD ( Supplementary  Fig. 6 ). Reciprocally, the GBD induces folding of the unstructured R33 (Supplementary Figs 6B and 7). Titrations of R33 and R47 5 into GBD saturated at 1:1 and 0.2:1 EspF U :GBD stoichiometry, respectively, showing that each repeat can bind N-WASP. The endpoint spectra are similar, indicating that the GBD folds to the same structure on each repeat, and that the molecular nature of allosteric activation can be understood through analysis of the R33 complex.
We determined the solution structure of the WASP GBD in complex with EspF U R33 (GBD-R33) using NMR spectroscopy (Fig 2,  Supplementary Fig. 8 and Supplementary Table 1 ). The complex can be considered in three stacked structural layers 7 . The first layer is composed of a short N-terminal i14 b hairpin (b1, 252-253; b2, 257-258; two backbone hydrogen bonds between D253 and G257) and a1 helix (265-274) from the GBD. The second layer lies behind the first and consists of GBD helices a2-a4 (a2, 278-281; a3, 284-296; a4, 300-306), which have a roughly planar C-shaped arrangement. The third layer is an amphipathic a5 helix (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) and an extended arm (16) (17) (18) (19) (20) from EspF U . These elements contact the back of the GBD and are roughly antiparallel to a3 and a2, respectively (Fig. 2a , structural details in Supplementary Fig. 9 ). On the basis of the absence of long-range Fig. 10 ). The EspF U relative, EspF, is expected to bind to the GBD through an analogous amphipathic a5 helix, but may not use an extended arm as these C-terminal residues are not conserved ( Supplementary Fig. 1 ).
To understand the physical basis of EspF U activity better, we examined a series of single repeat mutants on the basis of the structure. First, we C-terminally fused these proteins to the WASP GBD through a short linker. Because the GBD and R33 are only folded when bound to each other, the thermodynamic stability of the fusions reports on the relative strengths of interaction between the two elements. We mutated three conserved hydrophobic residues (V4, L8 and L12) which lie at the centre of the interface between a5 and the GBD (Supplementary Fig. 9 ). The L12A (R33 VL *) and V4A/L8A (R33** L ) mutants have substantially reduced stability relative to wild type in the GBD-R33 fusions ( Fig. 1d and Supplementary  Fig. 11 ), demonstrating the importance of a5 in the interaction of N-WASP with EspF U . Truncations from R33 to R30 or R27 decrease stability by ,2 kcal mol 21 . Thus, residues beyond Ala 30 contribute thermodynamically to the GBD-R33 interaction, despite the absence of discrete structure in these regions. Similar contributions to affinity through disordered regions have also been observed in other systems 24 . Truncation of all (R14) or part (R18) of the EspF U C-terminal arm decreases the stability further, indicating that the arm contributes appreciably to binding of the GBD to EspF U . These unfolding studies mirror direct binding measurements. R33 and R18 bind N-WASP C with K d values of 35 and 4,000 nM, respectively (Fig. 1d) , corresponding to a difference in free energy of 2.9 kcal mol
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. This value agrees closely with the stability difference between the two GBD fusions (2.6 kcal mol 21 ; Fig. 1d ). Furthermore, these differences in binding correspond well to the activities of the EspF U mutants in N-WASP-mediated actin assembly assays, in which activity decreases together with the strength of interaction (Fig. 1b, d ).
To test how the biophysical properties of the EspF U -N-WASP interaction relate to biological function, we examined the ability of EspF U derivatives to induce localized actin assembly in mammalian cells. To uncouple Tir-mediated recruitment of EspF U from EspF U function in pedestal generation after recruitment, we replaced the C-terminal cytoplasmic domain of Tir with two repeats of EspF U (giving rise to TirDC-R47 2 ). We expressed TirDC-R47 2 in mouse fibroblast-like cells, where it inserted into the plasma membrane, and then clustered it by adding E. coli expressing intimin.
Immunostaining showed that foci of clustered Tir and N-WASP coincided with bound bacteria (Fig. 3a) . Similarly, F-actin strongly colocalized with Tir. In contrast, a control Tir derivative (TirDC) lacking cytoplasmic elements did not recruit N-WASP or produce actin pedestals (Fig. 3) . Mutation of Leu 12 to Ala in both EspF U repeats (giving TirDC-R47 2 VL *) also abolished both actin assembly and N-WASP recruitment (Fig. 3a) , consistent with the decreased binding of this mutant to N-WASP in vitro (Fig. 1) . To examine the activity of EspF U truncation mutants, we modified this assay to analyse derivatives of one EspF U repeat unit. As predicted by in vitro data (Fig. 1) , the triple V4A/L8A/L12A mutant, TirDC-R47***, was also unable to assemble actin (Supplementary Fig. 12 ). Truncation of R47 to R33 decreased activity, probably owing to the loss of most of the proline-rich region, which in EspF is known to bind SH3-containing proteins to promote actin assembly 23 ( Fig. 3b ). R30 and R27 showed even lower actin assembly levels, consistent with the diminished N-WASP C binding by these proteins compared to R33 (Fig. 1) . Furthermore, R14, which bound N-WASP C only very weakly (Fig. 1) , did not promote actin assembly above background amounts. Together, these data show that the ability of EspF U derivatives to promote actin assembly in vivo reflects the physical interactions between EspF U and WASP in vitro.
The complexes of the GBD with R33 and with the C region of the VCA (GBD-C) are highly similar (Fig. 2) . In both cases, ligand binding causes the GBD to fold into a b-hairpin and four helices. average GBD coordinates in the two structures is only 0.95 Å (residues 247-310 The largest chemical shift differences between the two complexes occur in a2, which contacts the extended arm of EspF U in the GBD-R33 complex, but is solvent exposed in the GBD-C complex. The WASP C helix and the EspF U helix bind the GBD at the same site and orientation through analogous hydrophobic contacts involving similar sequences (Fig. 1a and Supplementary Fig. 9 ). EspF U makes further contacts to the GBD through its C-terminal arm, which are not seen in the bound C region helix in autoinhibited WASP. These contacts contribute to the much higher WASP affinity of EspF U compared to its eukaryotic counterparts 21 . The combined structural and biochemical data lead to a clear and simple mechanism for WASP and N-WASP activation by a single repeat element of EspF U : displacement of the VCA through competitive binding to a common site on the folded GBD.
We have described the autoinhibited GBD-VCA structure as composed of three layers, analogous to the three layers of the GBD-R33 structure, with the C region of the VCA substituting for R33 (ref. 7) . Three structurally distinct mechanisms for relieving autoinhibition of WASP and N-WASP are now known that involve attacks on distinct regions of this fold ( Supplementary Fig. 13 ). Cdc42 globally destabilizes the GBD by binding to the first layer of structure. Similarly, following phosphorylation of the conserved Tyr 291 and Tyr 256 in WASP and N-WASP respectively, SH2 domains can also destabilize the GBD by binding to this site in the second layer. EHEC has evolved the simplest and structurally most direct means of releasing the VCA: EspF U binds to the GBD-VCA interface, displacing the VCA from the folded GBD by structural competition. Of the three known allosteric mechanisms, only this latter one is akin to those found in most other autoinhibited multidomain systems, in which activation is driven by rearrangements of intact functional modules. The diversity of WASP regulation probably originates from the intrinsically unstructured nature of the GBD, which enables its broad binding specificity. Because the folded GBD is structurally incompatible with Cdc42/SH2 binding, EspF U can displace the VCA while simultaneously preventing interactions with eukaryotic activators, thus sequestering WASP proteins away from their normal signalling pathways. This, coupled with very high affinity binding, allows EHEC to subvert the host actin cytoskeleton to its own ends.
METHODS SUMMARY
Protein expression and purification. EspF U and WASP proteins were expressed in bacteria as either His 6 -or glutathione S-transferase (GST)-fusions, and purified by affinity and conventional chromatographies. The bovine Arp2/3 complex and rabbit skeletal muscle actin were purified as described 25, 26 . Biochemical assays. All biochemical assays were performed in KMEI buffer (10 mM imidazole pH 7.0, 50 mM KCl, 1 mM MgCl 2 and 1 mM EGTA), or KMEI plus 5 mM b-mercaptoethanol at 25 uC. Actin assembly assays were performed as described 25 , with 4 mM actin (5% pyrene labelled) and 10 nM Arp2/3 complex. Filament barbed end concentrations were calculated as described 27 . GBD-EspF U fusion proteins (10 mM) were denatured using guanidine hydrochloride. Tryptophan fluorescence emission (l ex 5 295 nm, l em 5 320 nm and 355 nm) was fitted to a six parameter equation 28 to yield DG unfolding . EspF U proteins were titrated into N-WASP C in a Microcal VP-ITC microcalorimeter. Baseline was corrected for EspF U addition to buffer. Data were fit to a single-site binding model. Mammalian cell culture. Mouse fibroblast-like cells were transfected with HATir-EspF U fusions as described 1 . Transfected cells were treated with E. coli expressing intimin for 3.5 h (for Tir-R47 2 fusions) or antibodies recognizing the extracellular domain of EHEC Tir (gift from A. Donohue-Rolfe), followed by Staphylococcus aureus particles (Pansorbin; Calbiochem) (for Tir fusions with a single EspF U repeat). Immunofluorescence microscopy. Monolayers were fixed and permeabilized as described 29 . Cells were treated with HA.11 or anti-N-WASP (gift from S. Snapper), washed and treated with Alexa488 goat anti-mouse antibody (1:200; Molecular Probes) or Alexa568 goat anti-rabbit antibody (1:150; Molecular Probes), respectively. F-actin was stained with Alexa568-phalloidin (1:100; Molecular Probes). NMR spectroscopy and structure calculation. The structure of the complex of GBD (residues 242-310) and R33 (residues 1-33 in Fig. 1 , corresponding to residues 268-300 in EspF U ; Supplementary Fig. 1 ) was determined in iterative fashion on the basis of NOE, dihedral and hydrogen bond restraints using ARIA 2.1 (ref. 30) .
Full Methods and any associated references are available in the online version of the paper at www.nature.com/nature.
